Fresenius Settles With Johnson & Johnson to Market Stelara Alternative Global News Select Mar 18, 2024 9:51am
Dialysis-company stocks slide after Ozempic trial's success in treating kidney disease MarketWatch Oct 11, 2023 2:54pm
Fresenius Shares Slump After Novo Nordisk Kidney Disease Trial Shows Efficacy Global News Select Oct 11, 2023 9:38am